vs
艾伯维（ABBV）与摩根士丹利（MS）财务数据对比。点击上方公司名可切换其他公司
摩根士丹利的季度营收约是艾伯维的1.1倍（$17.9B vs $16.6B），摩根士丹利净利率更高（24.6% vs 10.9%，领先13.7%）
艾伯维是一家总部位于美国伊利诺伊州北芝加哥的制药企业，专注于研发、生产覆盖多种疾病领域的治疗药物，致力于为全球各地患者提供安全有效的临床解决方案，在全球医药行业拥有较高的知名度与影响力。
摩根士丹利是总部位于美国纽约曼哈顿中城百老汇1585号的跨国投资银行及金融服务提供商，在全球42个国家设有办事处，员工超8万名，服务客户涵盖企业、政府、机构及个人。2023年该公司位列美国财富500强第61位，同年位居福布斯全球2000强第30位。
ABBV vs MS — 直观对比
营收规模更大
MS
是对方的1.1倍
$16.6B
净利率更高
MS
高出13.7%
10.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.6B | $17.9B |
| 净利润 | $1.8B | $4.4B |
| 毛利率 | 72.6% | — |
| 营业利润率 | 27.3% | 32.2% |
| 净利率 | 10.9% | 24.6% |
| 营收同比 | 10.0% | — |
| 净利润同比 | 8354.5% | — |
| 每股收益（稀释后） | $1.02 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABBVMS
| Q4 25 | $16.6B | $17.9B | ||
| Q3 25 | $15.8B | $18.2B | ||
| Q2 25 | $15.4B | $16.8B | ||
| Q1 25 | $13.3B | $17.7B | ||
| Q4 24 | $15.1B | — | ||
| Q3 24 | $14.5B | $15.4B | ||
| Q2 24 | $14.5B | $15.0B | ||
| Q1 24 | $12.3B | $15.1B |
净利润ABBVMS
| Q4 25 | $1.8B | $4.4B | ||
| Q3 25 | $186.0M | $4.6B | ||
| Q2 25 | $938.0M | $3.5B | ||
| Q1 25 | $1.3B | $4.3B | ||
| Q4 24 | $-22.0M | — | ||
| Q3 24 | $1.6B | $3.2B | ||
| Q2 24 | $1.4B | $3.1B | ||
| Q1 24 | $1.4B | $3.4B |
毛利率ABBVMS
| Q4 25 | 72.6% | — | ||
| Q3 25 | 66.4% | — | ||
| Q2 25 | 71.8% | — | ||
| Q1 25 | 70.0% | — | ||
| Q4 24 | 70.9% | — | ||
| Q3 24 | 70.9% | — | ||
| Q2 24 | 70.9% | — | ||
| Q1 24 | 66.7% | — |
营业利润率ABBVMS
| Q4 25 | 27.3% | 32.2% | ||
| Q3 25 | 12.1% | 33.1% | ||
| Q2 25 | 31.7% | 27.5% | ||
| Q1 25 | 28.0% | 31.3% | ||
| Q4 24 | -9.9% | — | ||
| Q3 24 | 26.5% | 27.4% | ||
| Q2 24 | 27.6% | 27.1% | ||
| Q1 24 | 22.7% | 29.0% |
净利率ABBVMS
| Q4 25 | 10.9% | 24.6% | ||
| Q3 25 | 1.2% | 25.3% | ||
| Q2 25 | 6.1% | 21.1% | ||
| Q1 25 | 9.6% | 24.3% | ||
| Q4 24 | -0.1% | — | ||
| Q3 24 | 10.8% | 20.7% | ||
| Q2 24 | 9.5% | 20.5% | ||
| Q1 24 | 11.1% | 22.5% |
每股收益（稀释后）ABBVMS
| Q4 25 | $1.02 | $2.68 | ||
| Q3 25 | $0.10 | $2.80 | ||
| Q2 25 | $0.52 | $2.13 | ||
| Q1 25 | $0.72 | $2.60 | ||
| Q4 24 | $-0.03 | — | ||
| Q3 24 | $0.88 | $1.88 | ||
| Q2 24 | $0.77 | $1.82 | ||
| Q1 24 | $0.77 | $2.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.3B | $111.7B |
| 总债务越低越好 | $58.9B | $341.7B |
| 股东权益账面价值 | $-3.3B | $111.6B |
| 总资产 | $134.0B | $1420.3B |
| 负债/权益比越低杠杆越低 | — | 3.06× |
8季度趋势，按日历期对齐
现金及短期投资ABBVMS
| Q4 25 | $5.3B | $111.7B | ||
| Q3 25 | $5.7B | $103.7B | ||
| Q2 25 | $6.5B | $109.1B | ||
| Q1 25 | $5.2B | $90.7B | ||
| Q4 24 | $5.6B | — | ||
| Q3 24 | $7.3B | $91.1B | ||
| Q2 24 | $13.2B | $90.2B | ||
| Q1 24 | $18.1B | $102.3B |
总债务ABBVMS
| Q4 25 | $58.9B | $341.7B | ||
| Q3 25 | $63.0B | $324.1B | ||
| Q2 25 | $63.0B | $320.1B | ||
| Q1 25 | $64.5B | $297.0B | ||
| Q4 24 | $60.3B | — | ||
| Q3 24 | $58.5B | $291.2B | ||
| Q2 24 | $58.0B | $269.9B | ||
| Q1 24 | $63.8B | $266.1B |
股东权益ABBVMS
| Q4 25 | $-3.3B | $111.6B | ||
| Q3 25 | $-2.6B | $110.0B | ||
| Q2 25 | $-183.0M | $108.2B | ||
| Q1 25 | $1.4B | $106.8B | ||
| Q4 24 | $3.3B | — | ||
| Q3 24 | $6.0B | $103.6B | ||
| Q2 24 | $6.8B | $100.7B | ||
| Q1 24 | $8.0B | $99.2B |
总资产ABBVMS
| Q4 25 | $134.0B | $1420.3B | ||
| Q3 25 | $133.9B | $1364.8B | ||
| Q2 25 | $137.2B | $1353.9B | ||
| Q1 25 | $136.2B | $1300.3B | ||
| Q4 24 | $135.2B | — | ||
| Q3 24 | $143.4B | $1258.0B | ||
| Q2 24 | $141.9B | $1212.4B | ||
| Q1 24 | $148.9B | $1228.5B |
负债/权益比ABBVMS
| Q4 25 | — | 3.06× | ||
| Q3 25 | — | 2.95× | ||
| Q2 25 | — | 2.96× | ||
| Q1 25 | 45.44× | 2.78× | ||
| Q4 24 | 18.15× | — | ||
| Q3 24 | 9.70× | 2.81× | ||
| Q2 24 | 8.56× | 2.68× | ||
| Q1 24 | 7.97× | 2.68× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.2B | $-2.4B |
| 自由现金流经营现金流 - 资本支出 | $4.9B | — |
| 自由现金流率自由现金流/营收 | 29.4% | — |
| 资本支出强度资本支出/营收 | 2.0% | — |
| 现金转化率经营现金流/净利润 | 2.87× | -0.55× |
| 过去12个月自由现金流最近4个季度 | $17.8B | — |
8季度趋势，按日历期对齐
经营现金流ABBVMS
| Q4 25 | $5.2B | $-2.4B | ||
| Q3 25 | $7.0B | $-3.3B | ||
| Q2 25 | $5.2B | $11.8B | ||
| Q1 25 | $1.6B | $-24.0B | ||
| Q4 24 | $7.0B | — | ||
| Q3 24 | $5.4B | — | ||
| Q2 24 | $2.3B | — | ||
| Q1 24 | $4.0B | $4.4B |
自由现金流ABBVMS
| Q4 25 | $4.9B | — | ||
| Q3 25 | $6.6B | — | ||
| Q2 25 | $4.9B | — | ||
| Q1 25 | $1.4B | — | ||
| Q4 24 | $6.8B | — | ||
| Q3 24 | $5.2B | — | ||
| Q2 24 | $2.0B | — | ||
| Q1 24 | $3.8B | — |
自由现金流率ABBVMS
| Q4 25 | 29.4% | — | ||
| Q3 25 | 42.1% | — | ||
| Q2 25 | 31.7% | — | ||
| Q1 25 | 10.5% | — | ||
| Q4 24 | 44.7% | — | ||
| Q3 24 | 35.9% | — | ||
| Q2 24 | 14.0% | — | ||
| Q1 24 | 31.3% | — |
资本支出强度ABBVMS
| Q4 25 | 2.0% | — | ||
| Q3 25 | 2.4% | — | ||
| Q2 25 | 1.7% | — | ||
| Q1 25 | 1.8% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 1.7% | — | ||
| Q1 24 | 1.6% | — |
现金转化率ABBVMS
| Q4 25 | 2.87× | -0.55× | ||
| Q3 25 | 37.76× | -0.72× | ||
| Q2 25 | 5.49× | 3.34× | ||
| Q1 25 | 1.27× | -5.56× | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.49× | — | ||
| Q2 24 | 1.66× | — | ||
| Q1 24 | 2.95× | 1.28× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
